These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 21477627

  • 1. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X, Zhang XA, Wang DW.
    Adv Drug Deliv Rev; 2011 Jul 18; 63(8):597-609. PubMed ID: 21477627
    [Abstract] [Full Text] [Related]

  • 2. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
    Chen C, Wang DW.
    Curr Top Med Chem; 2013 Jul 18; 13(12):1454-69. PubMed ID: 23688135
    [Abstract] [Full Text] [Related]

  • 3. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P, Siest G, Visvikis-siest S.
    Drug Metab Rev; 2014 Feb 18; 46(1):33-56. PubMed ID: 24040964
    [Abstract] [Full Text] [Related]

  • 4. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P, Siest G, Meyer UA, Visvikis-Siest S.
    Pharmacol Ther; 2014 Nov 18; 144(2):134-61. PubMed ID: 24882266
    [Abstract] [Full Text] [Related]

  • 5. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
    Zordoky BN, El-Kadi AO.
    Pharmacol Ther; 2010 Mar 18; 125(3):446-63. PubMed ID: 20093140
    [Abstract] [Full Text] [Related]

  • 6. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA, Hanif A, Geldenhuys WJ, Agba S.
    Pharmacol Ther; 2022 Dec 18; 240():108213. PubMed ID: 35597366
    [Abstract] [Full Text] [Related]

  • 7. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K, Tauber Z.
    Acta Histochem; 2018 Aug 18; 120(6):513-519. PubMed ID: 29908721
    [Abstract] [Full Text] [Related]

  • 8. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
    Spiecker M, Liao JK.
    Arch Biochem Biophys; 2005 Jan 15; 433(2):413-20. PubMed ID: 15581597
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J, Joannides R.
    J Cardiovasc Pharmacol; 2013 Mar 15; 61(3):188-96. PubMed ID: 23011468
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y, Theken KN, Lee CR.
    J Mol Cell Cardiol; 2010 Feb 15; 48(2):331-41. PubMed ID: 19891972
    [Abstract] [Full Text] [Related]

  • 13. Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.
    Ni GH, Chen JF, Chen XP, Yang TL.
    Pharmazie; 2011 Mar 15; 66(3):153-7. PubMed ID: 21553642
    [Abstract] [Full Text] [Related]

  • 14. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model.
    Batchu SN, Law E, Brocks DR, Falck JR, Seubert JM.
    J Mol Cell Cardiol; 2009 Jan 15; 46(1):67-74. PubMed ID: 18973759
    [Abstract] [Full Text] [Related]

  • 15. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
    Nayeem MA, Geldenhuys WJ, Hanif A.
    Adv Pharmacol; 2023 Jan 15; 97():37-131. PubMed ID: 37236764
    [Abstract] [Full Text] [Related]

  • 16. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
    Nakayama K, Nitto T, Inoue T, Node K.
    Life Sci; 2008 Aug 29; 83(9-10):339-45. PubMed ID: 18675280
    [Abstract] [Full Text] [Related]

  • 17. Inside epoxyeicosatrienoic acids and cardiovascular disease.
    Tacconelli S, Patrignani P.
    Front Pharmacol; 2014 Aug 29; 5():239. PubMed ID: 25426071
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
    Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Nayeem MA.
    PLoS One; 2017 Aug 29; 12(3):e0174137. PubMed ID: 28328948
    [Abstract] [Full Text] [Related]

  • 19. Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
    Bellien J, Joannides R, Richard V, Thuillez C.
    Pharmacol Ther; 2011 Jul 29; 131(1):1-17. PubMed ID: 21514320
    [Abstract] [Full Text] [Related]

  • 20. Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells.
    Jiang JG, Shen GF, Chen C, Fu XN, Wang DW.
    Ai Zheng; 2009 Jan 29; 28(1):14-9. PubMed ID: 19448409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.